J 2020

HPV, protein p16 and squamous cell carcinoma of the oral cavity

BLAHÁK, Jiří; Jiří ZELINKA; Jaromír GUMULEC; Ctirad MACHÁČEK; Zdeněk DANĚK et al.

Basic information

Original name

HPV, protein p16 and squamous cell carcinoma of the oral cavity

Edition

Biomedical Papers, Olomouc, Univerzita Palackého v Olomouci, 2020, 1213-8118

Other information

Language

English

Type of outcome

Article in a journal

Field of Study

30109 Pathology

Country of publisher

Czech Republic

Confidentiality degree

is not subject to a state or trade secret

References:

Impact factor

Impact factor: 1.245

Marked to be transferred to RIV

Yes

RIV identification code

RIV/00216224:14110/20:00116360

Organization unit

Faculty of Medicine

EID Scopus

Keywords in English

oral squamous cell carcinoma; oral cancer; HPV; human papilloma virus; p16

Tags

International impact, Reviewed
Changed: 5/1/2021 12:04, Mgr. Tereza Miškechová

Abstract

In the original language

Background: Squamous cell carcinoma of the oral cavity is generally caused by the long-term impact of known risk factors, e.g. tobacco and alcohol, along with chronic traumatisation. A number of studies now implicate HPV infection in head and neck tumour carcinogenesis but the exact role of HPV infection in the oral cavity remains unclear. Methods: In this study, we evaluated 78 patients with oral squamous cell carcinoma (OSCC) for the expression of protein p16 in the context of HPV positivity and its influence on the overall survival rate, disease location, staging and grading. Results: Regarding the tumour location, no significant difference was found between HPV-positive and HPV-negative patients, nor between p16-positive and p16-negative patients. There was also no trend in terms of HPV status and stage, and differentiation of carcinoma. There was no effect on HPV-positive patients relative to the time to progression (P=0.84) and overall survival rate (P=0.78). P16 positivity was not found to have an effect on the overall survival rate of patients (P=0.41) and there was no correlation between p16 positivity relative to the time to progression (P=0.66). Conclusions: In summary, the data suggest that there is no effect of HPV status on the prognosis of OSCC patients compared to other HNSCC locations.